Lifecore Biomedical, Inc. (FRA:LDE)

Lifecore Biomedical Ratios and Metrics

Market cap in millions EUR. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	May 25, 2025	May 26, 2024	May 28, 2023	May 29, 2022	May 30, 2021
Market Capitalization	274	220	158	225	272	288
Market Cap Growth	19.55%	38.80%	-29.68%	-17.19%	-5.72%	2.86%
Enterprise Value	414	370	281	369	396	464
Last Close Price	6.95	5.80	5.15	7.65	8.90	9.25
PE Ratio	-	-	14.29	-	-	-
PS Ratio	2.41	1.93	1.34	2.33	2.62	3.48
PB Ratio	6.55	5.25	3.19	6.86	3.31	1.73
P/TBV Ratio	-	-	-	-	4.17	2.45
P/OCF Ratio	-	-	667.99	-	-	21.32
EV/Sales Ratio	3.81	3.25	2.37	3.82	3.81	5.61
EV/EBITDA Ratio	-	-	397.55	-	29.82	69.55
EV/EBIT Ratio	-	-	-	-	-	192.89
EV/FCF Ratio	-34.43	-	-	-	-	-
Debt / Equity Ratio	2.76	2.76	2.39	3.21	1.71	1.07
Debt / EBITDA Ratio	-	-	101.44	-	9.63	21.03
Asset Turnover	0.52	0.52	0.51	0.39	0.29	0.19
Inventory Turnover	2.45	2.45	2.14	1.96	1.46	0.96
Quick Ratio	1.46	1.46	1.02	1.23	0.22	0.42
Current Ratio	2.84	2.84	2.09	2.39	0.66	1.46
Return on Equity (ROE)	-76.41%	-76.41%	20.97%	-104.52%	-10.65%	-10.80%
Return on Assets (ROA)	-3.04%	-3.04%	-1.77%	-4.67%	-0.55%	0.35%
Return on Invested Capital (ROIC)	-7.01%	-6.98%	-4.66%	-10.79%	-1.05%	0.67%
Return on Capital Employed (ROCE)	-5.70%	-5.70%	-3.30%	-9.20%	-3.50%	0.70%
Earnings Yield	-14.28%	-15.56%	7.00%	-41.36%	-40.11%	-9.20%
FCF Yield	-4.39%	-5.47%	-10.56%	-16.17%	-18.05%	-2.49%
Buyback Yield / Dilution	5.02%	5.02%	-22.36%	-1.67%	-0.59%	-0.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.